Long-term outcomes of anti-thyroid drug treatment in childhood-onset Graves' disease.
Dolrutai PuttawongPat MahachoklertwattanaPawin NumthavajPatarawan WoratanaratSarunyu PongratanakulPeeravit KoadPreamrudee PoomthavornPublished in: Clinical endocrinology (2022)
Remission rate of childhood-onset GD was relatively low following ATD treatment. Longer-term ATD therapy was associated with increased remission rate. Approximately 50% of patients with relapse had disease relapse within 1 year following ATD discontinuation.